Plasma cross linked fibrin degradation products in pulmonary embolism.

B J Rowbotham, J Egerton-Vernon, A N Whitaker, M J Elms, I H Bunce

University of Queensland, Department of Pathology, Australia.

Plasma concentrations of cross linked fibrin degradation products, a marker of intravascular thrombosis and fibrinolysis, were measured in 495 patients with suspected pulmonary embolism referred for ventilation-perfusion lung scanning to determine whether concentrations are increased in pulmonary embolism and their potential use in diagnosis. Lung scans were described as normal (n = 66) or as showing a low (n = 292), indeterminate (n = 58), or high probability (n = 79) of pulmonary embolism. There was a difference between the mean levels of cross linked fibrin degradation products in each scan category: normal scans, 142 ng/ml; low probability scans, 295 ng/ml; indeterminate probability scans, 510 ng/ml; high probability scans, 952 ng/ml (p less than 0.001). Of the patients with high probability scans, 96% had raised concentrations. Explanations for discrepant low results include incorrect scan diagnosis, delay in blood sampling, and anticoagulation. Of the patients with a low or indeterminate probability of pulmonary embolism, 43% had increased concentrations of cross linked fibrin degradation products that could be attributed in most cases to another illness. Owing to the wide range of values in each lung scan diagnostic category, raised concentrations of these fibrin degradation products cannot be used without reference to the patient's clinical state as a discriminatory test for pulmonary embolism. Further evaluation of the significance of normal concentrations in excluding a diagnosis of pulmonary embolism appears to be warranted.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Blackwell, K., Haroon, Z., Broadwater, G., Berry, D., Harris, L., Iglehart, J. D., Dewhirst, M., Greenberg, C. (2000). Plasma D-Dimer Levels in Operable Breast Cancer Patients Correlate With Clinical Stage and Axillary Lymph Node Status. JCO 18: 600-600 [Abstract] [Full Text]  
• (1999). Proceedings of the European Symposium on Strategies in Diagnosis of Venous Thromboembolism, June 18, 1999 Utrecht, The Netherlands. CLIN APPL THROMB HEMOST 5: 216-227  
• QUINN, D. A., FOGEL, R. B., SMITH, C. D., LAPOSATA, M., THOMPSON, B. T., JOHNSON, S. M., WALTMAN, A. C., HALES, C. A. (1999). D-Dimers in the Diagnosis of Pulmonary Embolism. Am. J. Respir. Crit. Care Med. 159: 1445-1449 [Abstract] [Full Text]  
• Lee, L. V., Ewald, G. A., McKenzie, C. R., Eisenberg, P. R. (1997). The Relationship of Soluble Fibrin and Cross-linked Fibrin Degradation Products to the Clinical Course of Myocardial Infarction. Arterioscler. Thromb. Vasc. Bio. 17: 628-633 [Abstract] [Full Text]  
• Harvey, R. L., Roth, E. J., Yarnold, P. R., Durham, J. R., Green, D. (1996). Deep Vein Thrombosis in Stroke: The Use of Plasma D-Dimer Level as a Screening Test in the Rehabilitation Setting. Stroke 27: 1516-1520 [Abstract] [Full Text]  
• Goldhaber, S. Z., Simons, G. R., Elliott, C. G., Haire, W. D., Toltzis, R., Blacklow, S. C., Doolittle, M. H., Weinberg, D. S. (1993). Quantitative Plasma D-dimer Levels Among Patients Undergoing Pulmonary Angiography for Suspected Pulmonary Embolism. JAMA 270: 2819-2822 [Abstract]